Home › Funds › SymBiosis Capital Partners, LLC › WVE
SymBiosis Capital Partners, LLC position in WVE
WAVE LIFE SCIENCES INC · Health Care
SymBiosis Capital Partners, LLC reported holding 750,000 shares of WVE (WAVE LIFE SCIENCES INC) in its Q1 2026 13F filing — a position valued at US$5.4M, representing 10.30% of its reported portfolio and ranking #3 among its reported holdings. SymBiosis Capital Partners, LLC first reported this position in Q1 2026.
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
How SymBiosis Capital Partners, LLC's WVE position evolved
SymBiosis Capital Partners, LLC first disclosed a stake in WVE in Q1 2026 at 750,000 shares (US$5.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 750.00K | $5.44M | New |
About WVE and 13F data
WVE (WAVE LIFE SCIENCES INC) is a Health Care company. 35 other funds we track also report a position in WVE — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$156.7M), GSK plc (US$106.0M), Maverick Capital (US$59.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding WVE
- RA CAPITAL MANAGEMENT, L.P. 26.98M sh · $156.73M · Q2 2026
- GSK plc 18.25M sh · $106.01M · Q2 2026
- Maverick Capital 10.28M sh · $59.72M · Q2 2026
- MAVERICK CAPITAL LTD 10.28M sh · $59.72M · Q2 2026
- 683 Capital Management, LLC 4.95M sh · $28.76M · Q2 2026
- READYSTATE ASSET MANAGEMENT LP 4.73M sh · $27.46M · Q2 2026
- M28 Capital Management LP 4.59M sh · $26.66M · Q2 2026
- PFIZER INC 1.88M sh · $10.93M · Q2 2026
More on SymBiosis Capital Partners, LLC
FAQ
How long has SymBiosis Capital Partners, LLC held WVE?
SymBiosis Capital Partners, LLC has disclosed WVE holdings in 1 of the last 1 reported quarters, going back to Q1 2026.
What is SymBiosis Capital Partners, LLC's current position in WVE?
As of Q1 2026, SymBiosis Capital Partners, LLC holds 750.00K shares of WVE (WAVE LIFE SCIENCES INC), valued at $5.44M, representing 10.30% of its reported portfolio and ranking #3.
Has SymBiosis Capital Partners, LLC been buying or selling WVE?
In the latest 13F filing (Q1 2026), SymBiosis Capital Partners, LLC newly opened its position in WVE.
Which other funds hold WVE?
Other major institutional holders of WVE include RA CAPITAL MANAGEMENT, L.P., GSK plc, Maverick Capital, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.